Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results